tiprankstipranks
Galmed Pharmaceuticals Embraces Market with New Sales Agreement
Company Announcements

Galmed Pharmaceuticals Embraces Market with New Sales Agreement

Galmed Pharmaceuticals (GLMD) has released an update.

Pick the best stocks and maximize your portfolio:

Galmed Pharmaceuticals Ltd. has entered into a sales agreement with JonesTrading Institutional Services LLC, allowing the company to issue and sell ordinary shares at their discretion. This strategic move signals Galmed’s effort to leverage market opportunities and could potentially impact its stock value as shares are sold in at-the-market offerings.

For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyGalmed files $200M mixed securities shelf
TipRanks Auto-Generated NewsdeskGalmed Pharmaceuticals Strengthens Financial Position Amid Losses
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App